Page last updated: 2024-08-17

cytidine monophosphate and Breast Neoplasms

cytidine monophosphate has been researched along with Breast Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Qiu, S; Sun, H; Wang, XJ; Zhang, AH	1
Gluckman, PD; Lobie, PE; Mitchell, MD; Pawella, L; Rahnama, F; Shafiei, F	1
Bystricky, K; Fleury, L; Gerus, M; Lavigne, AC; Richard-Foy, H	1

Reviews

1 review(s) available for cytidine monophosphate and Breast Neoplasms

Article	Year
Metabolomics in noninvasive breast cancer. Clinica chimica acta; international journal of clinical chemistry, 2013, Sep-23, Volume: 424 Topics: Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Cytidine Monophosphate; Early Diagnosis; Fatty Acids; Female; Glycerophosphates; Humans; Magnetic Resonance Spectroscopy; Mass Spectrometry; Metabolomics; Sensitivity and Specificity	2013

Other Studies

2 other study(ies) available for cytidine monophosphate and Breast Neoplasms

Article	Year
DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells. Oncogene, 2008, Apr-17, Volume: 27, Issue:18 Topics: Antimetabolites, Antineoplastic; Apoptosis; Autocrine Communication; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytidine Monophosphate; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; DNA, Neoplasm; Female; gamma Catenin; Gene Expression Regulation, Neoplastic; Growth Hormone; Humans; Neoplasm Proteins; Phenotype; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering	2008
Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells. Oncogene, 2008, Jul-03, Volume: 27, Issue:29 Topics: Breast Neoplasms; Cell Line, Tumor; CpG Islands; Cytidine Monophosphate; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Receptors, Progesterone; RNA, Small Interfering	2008

Article

Year

DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells.

Oncogene, 2008, Apr-17, Volume: 27, Issue:18

Topics: Antimetabolites, Antineoplastic; Apoptosis; Autocrine Communication; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cytidine Monophosphate; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; DNA, Neoplasm; Female; gamma Catenin; Gene Expression Regulation, Neoplastic; Growth Hormone; Humans; Neoplasm Proteins; Phenotype; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering

2008

Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.

Oncogene, 2008, Jul-03, Volume: 27, Issue:29

Topics: Breast Neoplasms; Cell Line, Tumor; CpG Islands; Cytidine Monophosphate; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Estradiol; Estrogen Receptor alpha; Estrogens; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Receptors, Progesterone; RNA, Small Interfering

2008